Article Versions Notes

Tal-Ben Ishay R, Shil A, Solomon S, Sadigurschi N, Abu-Kaf H, Meiri G, Flusser H, Michaelovski A, Dinstein I, Golan H, et al. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel. Genes. 2022; 13(1):36. https://doi.org/10.3390/genes13010036

Tal-Ben Ishay, Rotem, Apurba Shil, Shirley Solomon, Noa Sadigurschi, Hadeel Abu-Kaf, Gal Meiri, Hagit Flusser, Analya Michaelovski, Ilan Dinstein, Hava Golan, and et al. 2022. "Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel" Genes 13, no. 1: 36. https://doi.org/10.3390/genes13010036

Tal-Ben Ishay, R., Shil, A., Solomon, S., Sadigurschi, N., Abu-Kaf, H., Meiri, G., Flusser, H., Michaelovski, A., Dinstein, I., Golan, H., Davidovitch, N., & Menashe, I. (2022). Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel. Genes, 13(1), 36. https://doi.org/10.3390/genes13010036